TCRR Insider Trading - Tcr2 Therapeutics Inc

Saham Orang Dalam

3,577,270 shares

Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Lihat Saham dengan Peringkat Tertinggi

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Lihat Saham dengan Peringkat Tertinggi

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

N/A

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

N/A

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan Tcr2 Therapeutics Inc transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam	Rata-rata Keuntungan (%)	Saham Dimiliki	Terbagi Disesuaikan

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di TCRR / Tcr2 Therapeutics Inc. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan	Orang Dalam	Dilaporkan Saham	Dilaporkan Harga	Disesuaikan Saham	Disesuaikan Harga	Dasar Biaya	Hari-hari menuju Maksimal	Harga di Maksimal	Maksimal Keuntungan ($)	Maksimum Pengembalian (%)
2023-05-25	TANG KEVIN C	50,000	1.7200	50,000	1.7200	86,000	0	1.7500	1,500	1.74
2023-05-12	TANG KEVIN C	6,183	1.9500	6,183	1.9500	12,057
2023-05-11	TANG KEVIN C	38,765	1.9500	38,765	1.9500	75,592
2023-05-10	TANG KEVIN C	6,774	1.9500	6,774	1.9500	13,209
2023-05-09	TANG KEVIN C	20,141	1.9500	20,141	1.9500	39,275
2023-05-08	TANG KEVIN C	57,073	1.9500	57,073	1.9500	111,292
2023-05-05	TANG KEVIN C	95,759	1.9000	95,759	1.9000	181,942
2023-05-05	TANG KEVIN C	71,064	1.9400	71,064	1.9400	137,864
2023-05-04	TANG KEVIN C	104,241	1.8600	104,241	1.8600	193,888

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

TCRR / Tcr2 Therapeutics Inc Insider Trades

Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di TCRR / Tcr2 Therapeutics Inc. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan	Orang Dalam	Dilaporkan Saham	Dilaporkan Harga	Disesuaikan Saham	Disesuaikan Harga	Dasar Biaya	Hari-hari menuju Menit	Harga di Menit	Kerugian Maksimal Dihindari ($)	Kerugian Maksimal Dihindari (%)
2023-05-22	MPM ASSET MANAGEMENT LLC	70,170	1.8800	70,170	1.8800	131,920	9	1.4800	-28,067	-21.28
2020-03-20	Gibson Neil W	648	7.9400	648	7.9400	5,145
2020-03-19	Gibson Neil W	3,140	7.4100	3,140	7.4100	23,267
2020-03-18	Gibson Neil W	3,120	6.8300	3,120	6.8300	21,310
2020-03-17	Gibson Neil W	3,009	6.4900	3,009	6.4900	19,528
2020-03-16	Gibson Neil W	17,723	6.6040	17,723	6.6040	117,043
2020-03-13	Gibson Neil W	52,000	6.5172	52,000	6.5172	338,894
2019-12-19	Jovan-Embiricos Morana	6,642	16.4714	6,642	16.4714	109,403
2019-12-19	Jovan-Embiricos Morana	35,323	16.4714	35,323	16.4714	581,819

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas Tanggal	Perdagangan Tanggal	Formulir	Orang Dalam	Ticker	Judul Keamanan	Kode	Langsung	Latihan Harga	Satuan Harga	Unit Diubah	Nilai Diubah (1 ribu)	Sisa Pilihan	Sisa Saham
2024-02-14	2023-06-01	4	TANG KEVIN C By LP	TCRR	Common Stock	J - Other	I			-4,394,800			0
2023-06-05	2023-06-01	4	MPM BioVentures 2014, L.P.	TCRR	Common Stock	J - Other	I			-4,158,964			0
2023-06-05	2023-06-01	4	MPM SunStates Fund, L.P.	TCRR	Common Stock	J - Other	I			-4,158,964			0
2023-06-05	2023-06-01	4	UBS Oncology Impact Fund L.P.	TCRR	Common Stock	J - Other	D			-3,370,982			0
2023-06-05	2023-06-01	4	GADICKE ANSBERT	TCRR	Common Stock	J - Other	I			-3,370,982			0
2023-06-05	2023-06-01	4	GADICKE ANSBERT	TCRR	Common Stock	J - Other	I			-3,854,963			0
2023-06-05	2023-06-01	4	GADICKE ANSBERT	TCRR	Common Stock	J - Other	I			-304,001			0
2023-06-01	2023-06-01	4	Cardama Alfonso Quintas	TCRR	Common Stock	D - Sale to Issuer	D			-109,459			0
2023-06-01	2023-06-01	4	Olagunju Peter	TCRR	Common Stock	D - Sale to Issuer	D			-24,092			0
2023-06-01	2023-06-01	4	Menzel Garry E	TCRR	Common Stock	D - Sale to Issuer	D			-138,871			0
2023-06-01	2023-06-01	4	Menzel Garry E	TCRR	Common Stock	D - Sale to Issuer	I			-132,730			0
2023-06-01	2023-06-01	4	Menzel Garry E	TCRR	Common Stock	D - Sale to Issuer	I			-132,729			0
2023-06-01	2023-06-01	4	Justice Angela	TCRR	Common Stock	D - Sale to Issuer	D			-48,745			0
2023-05-30	2023-05-25	4	TANG KEVIN C By LP	TCRR	Common Stock	P - Purchase	I		1.7200	50,000	86		4,394,800
2023-05-24	2023-05-22	4	MPM ASSET MANAGEMENT LLC	TCRR	Common Stock	S - Sale	D		1.8800	-70,170	-132		304,001
2023-05-24	2023-05-22	4	MPM ASSET MANAGEMENT LLC	TCRR	Common Stock	X - Other	D		0.7400	178,269	132		374,171
2023-05-24	2023-05-22	4	GADICKE ANSBERT	TCRR	Common Stock	S - Sale	I		1.8800	-70,170	-132		304,001
2023-05-24	2023-05-22	4	GADICKE ANSBERT	TCRR	Common Stock	X - Other	I		0.7400	178,269	132		374,171
2023-05-15	2023-05-12	4	TANG KEVIN C By LP	TCRR	Common Stock	P - Purchase	I		1.9500	6,183	12		4,344,800
2023-05-15	2023-05-11	4	TANG KEVIN C By LP	TCRR	Common Stock	P - Purchase	I		1.9500	38,765	76		4,338,617
2023-05-10	2023-05-10	4	TANG KEVIN C By LP	TCRR	Common Stock	P - Purchase	I		1.9500	6,774	13		4,299,852
2023-05-10	2023-05-09	4	TANG KEVIN C By LP	TCRR	Common Stock	P - Purchase	I		1.9500	20,141	39		4,293,078
2023-05-10	2023-05-08	4	TANG KEVIN C By LP	TCRR	Common Stock	P - Purchase	I		1.9500	57,073	111		4,272,937
2023-05-05	2023-05-05	4	TANG KEVIN C By LP	TCRR	Common Stock	P - Purchase	I		1.9400	71,064	138		4,215,864
2023-05-05	2023-05-05	4	TANG KEVIN C By LP	TCRR	Common Stock	P - Purchase	I		1.9000	95,759	182		4,144,800
2023-05-05	2023-05-04	4	TANG KEVIN C By LP	TCRR	Common Stock	P - Purchase	I		1.8600	104,241	194		4,049,041
2023-05-05	2023-05-03	4	TANG KEVIN C By LP	TCRR	Common Stock	P - Purchase	I		1.8500	18,513	34		3,944,800
2023-05-05		3	TANG CAPITAL PARTNERS LP By LP	TCRR	Common Stock		I						3,926,287
2022-12-13	2022-12-13	4	Cardama Alfonso Quintas	TCRR	Common Stock	S - Sale	D		1.0610	-4,752	-5		109,459
2022-12-13	2022-12-12	4	Cardama Alfonso Quintas	TCRR	Common Stock	S - Sale	D		1.0990	-4,586	-5		114,211
2022-12-13	2022-12-09	4	Cardama Alfonso Quintas	TCRR	Common Stock	S - Sale	D		1.1300	-4,461	-5		118,797
2022-12-13	2022-12-13	4	Olagunju Peter	TCRR	Common Stock	S - Sale	D		1.0650	-1,659	-2		24,092
2022-12-13	2022-12-12	4	Olagunju Peter	TCRR	Common Stock	S - Sale	D		1.0970	-1,610	-2		25,751
2022-12-13	2022-12-09	4	Olagunju Peter	TCRR	Common Stock	S - Sale	D		1.1310	-1,561	-2		27,361
2022-12-13	2022-12-12	4	Justice Angela	TCRR	Common Stock	S - Sale	D		1.0630	-2,963	-3		48,745
2022-12-13	2022-12-12	4	Justice Angela	TCRR	Common Stock	S - Sale	D		1.0990	-2,865	-3		51,708
2022-12-13	2022-12-09	4	Justice Angela	TCRR	Common Stock	S - Sale	D		1.1280	-2,792	-3		54,573
2022-12-13	2022-12-13	4	Menzel Garry E	TCRR	Common Stock	S - Sale	D		1.0620	-11,000	-12		138,871
2022-12-13	2022-12-12	4	Menzel Garry E	TCRR	Common Stock	S - Sale	D		1.1000	-10,613	-12		149,871
2022-12-13	2022-12-09	4	Menzel Garry E	TCRR	Common Stock	S - Sale	D		1.1310	-10,325	-12		160,484
2022-12-09	2022-12-08	4	Cardama Alfonso Quintas	TCRR	Common Stock	S - Sale	D		1.2560	-4,014	-5		123,258
2022-12-09	2022-12-07	4	Cardama Alfonso Quintas	TCRR	Common Stock	S - Sale	D		1.2830	-3,928	-5		127,272
2022-12-09	2022-12-08	4	Justice Angela	TCRR	Common Stock	S - Sale	D		1.2550	-2,511	-3		57,365
2022-12-09	2022-12-07	4	Justice Angela	TCRR	Common Stock	S - Sale	D		1.2820	-2,457	-3		59,876
2022-12-09	2022-12-08	4	Menzel Garry E	TCRR	Common Stock	S - Sale	D		1.2540	-9,314	-12		170,809
2022-12-09	2022-12-07	4	Menzel Garry E	TCRR	Common Stock	S - Sale	D		1.2820	-9,111	-12		180,123
2022-12-09	2022-12-08	4	Olagunju Peter	TCRR	Common Stock	S - Sale	D		1.2530	-1,410	-2		28,922
2022-12-09	2022-12-07	4	Olagunju Peter	TCRR	Common Stock	S - Sale	D		1.2820	-1,378	-2		30,332
2022-12-07	2022-12-06	4	Cardama Alfonso Quintas	TCRR	Common Stock	S - Sale	D		1.3340	-3,778	-5		131,200
2022-12-07	2022-12-05	4	Cardama Alfonso Quintas	TCRR	Common Stock	S - Sale	D		1.3700	-3,686	-5		134,978
2022-12-07	2022-12-06	4	Menzel Garry E	TCRR	Common Stock	S - Sale	D		1.3490	-14,886	-20		189,234
2022-12-07	2022-12-05	4	Menzel Garry E	TCRR	Common Stock	S - Sale	D		1.3720	-8,530	-12		204,120
2022-12-07	2022-12-06	4	Olagunju Peter	TCRR	Common Stock	S - Sale	D		1.3300	-1,327	-2		31,710
2022-12-07	2022-12-05	4	Olagunju Peter	TCRR	Common Stock	S - Sale	D		1.3680	-1,291	-2		33,037
2022-12-07	2022-12-06	4	Justice Angela	TCRR	Common Stock	S - Sale	D		1.3340	-2,361	-3		62,333
2022-12-07	2022-12-05	4	Justice Angela	TCRR	Common Stock	S - Sale	D		1.3730	-2,302	-3		64,694
2022-12-05	2022-12-02	4	Justice Angela	TCRR	Common Stock	S - Sale	D		1.3910	-2,273	-3		66,996
2022-12-05	2022-12-01	4	Justice Angela	TCRR	Common Stock	M - Exercise	D			59,576			69,269
2022-12-05	2022-12-02	4	Menzel Garry E	TCRR	Common Stock	S - Sale	D		1.3900	-8,408	-12		212,650
2022-12-05	2022-12-01	4	Menzel Garry E	TCRR	Common Stock	M - Exercise	D			221,058			221,058
2022-12-05	2022-12-02	4	Cardama Alfonso Quintas	TCRR	Common Stock	S - Sale	D		1.3900	-3,636	-5		138,664
2022-12-05	2022-12-01	4	Cardama Alfonso Quintas	TCRR	Common Stock	M - Exercise	D			95,385			142,300
2022-12-05	2022-12-02	4	Olagunju Peter	TCRR	Common Stock	S - Sale	D		1.3870	-1,273	-2		34,328
2022-12-05	2022-12-01	4	Olagunju Peter	TCRR	Common Stock	M - Exercise	D			33,409			35,601
2022-08-26	2022-07-05	4	Menzel Garry E	TCRR	Common Stock	G - Gift	I			132,730			132,730
2022-08-26	2022-07-05	4	Menzel Garry E	TCRR	Common Stock	G - Gift	D			-132,730			0
2022-08-26	2022-07-05	4	Menzel Garry E	TCRR	Common Stock	G - Gift	I			48,202			132,729
2022-08-26	2022-07-05	4	Menzel Garry E	TCRR	Common Stock	G - Gift	D			-48,202			132,730
2022-08-26	2022-07-05	4	Menzel Garry E	TCRR	Common Stock	G - Gift	I			84,527			84,527
2022-08-26	2022-07-05	4	Menzel Garry E	TCRR	Common Stock	G - Gift	I			-84,527			0
2022-03-18	2022-02-28	4	Menzel Garry E	TCRR	Common Stock	A - Award	D		2.3000	1,425	3		180,932
2022-03-18	2022-02-28	4	Justice Angela	TCRR	Common Stock	A - Award	D		2.3000	2,236	5		9,693
2022-01-12	2022-01-10	4	Harrison Rosemary	TCRR	Stock Option (Right to Buy)	A - Award	D	4.04		191,102		191,102
2021-12-10	2021-12-09	4	Webster Stephen W	TCRR	Stock Option (Right to Buy)	A - Award	D	5.21		12,100		12,100
2021-12-10	2021-12-09	4	Tomasello Shawn	TCRR	Stock Option (Right to Buy)	A - Award	D	5.21		12,100		12,100
2021-12-10	2021-12-09	4	Olagunju Peter	TCRR	Stock Option (Right to Buy)	A - Award	D	5.21		47,100		47,100
2021-12-10	2021-12-09	4	Cardama Alfonso Quintas	TCRR	Stock Option (Right to Buy)	A - Award	D	5.21		114,700		114,700
2021-12-10	2021-12-09	4	Cardama Alfonso Quintas	TCRR	Stock Option (Right to Buy)	M - Exercise	D	0.74	0.7400	43,000	32	31,582
2021-12-10	2021-12-09	4	Cardama Alfonso Quintas	TCRR	Common Stock	M - Exercise	D		0.7400	43,000	32		46,915
2021-12-10	2021-08-31	4	Cardama Alfonso Quintas	TCRR	Common Stock	A - Award	D		14.2600	164	2		3,915
2021-12-10	2021-12-10	4	Menzel Garry E	TCRR	Stock Option (Right to Buy)	M - Exercise	D	0.74	0.7400	5,946	4	138,031
2021-12-10	2021-12-10	4	Menzel Garry E	TCRR	Stock Option (Right to Buy)	M - Exercise	D	0.74	0.7400	169,054	125	0
2021-12-10	2021-12-09	4	Menzel Garry E	TCRR	Stock Option (Right to Buy)	A - Award	D	5.21		305,800		305,800
2021-12-10	2021-12-09	4	Menzel Garry E	TCRR	Common Stock	M - Exercise	D		0.7400	175,000	130		179,507
2021-12-10	2021-08-31	4	Menzel Garry E	TCRR	Common Stock	A - Award	D		14.2600	422	6		4,507
2021-12-10	2021-12-09	4	Hoos Axel	TCRR	Stock Option (Right to Buy)	A - Award	D	5.21		12,100		12,100
2021-12-10	2021-12-09	4	Justice Angela	TCRR	Stock Option (Right to Buy)	A - Award	D	5.21		76,500		76,500
2021-12-10	2021-08-31	4	Justice Angela	TCRR	Common Stock	A - Award	D		14.2600	379	5		7,457
2021-12-10	2021-12-09	4	Hofmeister Robert	TCRR	Stock Option (Right to Buy)	A - Award	D	5.21		100,000		100,000
2021-12-10	2021-12-09	4	Gibson Neil W	TCRR	Stock Option (Right to Buy)	A - Award	D	5.21		12,100		12,100
2021-12-10	2021-12-09	4	Hegde Priti	TCRR	Stock Option (Right to Buy)	A - Award	D	5.21		12,100		12,100
2021-12-10	2021-12-09	4	Allen Andrew R	TCRR	Stock Option (Right to Buy)	A - Award	D	5.21		12,100		12,100
2021-08-26	2021-08-25	4	Hegde Priti	TCRR	Stock Option (Right to Buy)	A - Award	D	16.02		24,968		24,968
2021-07-27	2021-07-26	4	Olagunju Peter	TCRR	Stock Option (Right to Buy)	A - Award	D	12.69		286,367		286,367
2021-07-27		3	Olagunju Peter	TCRR	Common Stock		D						2,192
2021-04-02	2021-04-02	4	Justice Angela	TCRR	Stock Option (Right to Buy)	M - Exercise	D	14.81		-6,752		193,248
2021-04-02	2021-04-02	4	Justice Angela	TCRR	Common Stock	M - Exercise	D		14.8100	6,752	100		7,078
2021-03-08	2021-02-28	4	Cardama Alfonso Quintas	TCRR	Common Stock	A - Award	D		16.1245	708	11		3,751
2021-03-08	2020-08-31	4	Cardama Alfonso Quintas	TCRR	Common Stock	A - Award	D		10.0980	1,118	11		3,043
2021-03-08	2021-02-28	4	Justice Angela	TCRR	Common Stock	A - Award	D		16.1245	326	5		326
2021-03-08	2021-02-28	4	Menzel Garry E	TCRR	Common Stock	A - Award	D		16.1245	686	11		4,085
2021-03-08	2020-08-31	4	Menzel Garry E	TCRR	Common Stock	A - Award	D		10.0980	1,132	11		3,399
2021-02-04	2021-02-03	4	Tomasello Shawn	TCRR	Stock Option (Right to Buy)	A - Award	D	26.33		4,177		4,177
2021-02-04	2021-02-03	4	Tomasello Shawn	TCRR	Stock Option (Right to Buy)	A - Award	D	26.33		15,191		15,191
2020-12-23	2020-12-22	4	Hofmeister Robert	TCRR	Stock Option (Right to Buy)	M - Exercise	D	0.74		-7,000		28,732
2020-12-23	2020-12-22	4	Hofmeister Robert	TCRR	Common Stock	M - Exercise	D		0.7400	7,000	5		45,850
2020-12-16	2020-12-14	4	Somaiya Mayur Ian	TCRR	Stock Option (Right to Buy)	M - Exercise	D	5.88		2,000		102,558
2020-12-16	2020-12-14	4	Somaiya Mayur Ian	TCRR	Common Stock	S - Sale	D		35.0000	-2,000	-70		1,473
2020-12-16	2020-12-14	4	Somaiya Mayur Ian	TCRR	Common Stock	M - Exercise	D		5.8800	2,000	12		3,473
2020-12-11	2020-12-10	4	Allen Andrew R	TCRR	Stock Option (Right to Buy)	A - Award	D	31.83		12,100		12,100
2020-12-11	2020-12-10	4	Gibson Neil W	TCRR	Stock Option (Right to Buy)	A - Award	D	31.83		12,100		12,100
2020-12-11	2020-12-10	4	Justice Angela	TCRR	Stock Option (Right to Buy)	A - Award	D	31.83		67,000		67,000
2020-12-11	2020-12-10	4	Menzel Garry E	TCRR	Stock Option (Right to Buy)	A - Award	D	31.38		245,000		245,000
2020-12-11	2020-12-10	4	Baeuerle Patrick	TCRR	Stock Option (Right to Buy)	A - Award	D	31.83		12,100		12,100
2020-12-11	2020-12-10	4	Webster Stephen W	TCRR	Stock Option (Right to Buy)	A - Award	D	31.83		12,100		12,100
2020-12-11	2020-12-10	4	Hofmeister Robert	TCRR	Stock Option (Right to Buy)	A - Award	D	31.83		76,000		76,000
2020-12-11	2020-12-10	4	Cardama Alfonso Quintas	TCRR	Stock Option (Right to Buy)	A - Award	D	31.83		101,000		101,000
2020-12-11	2020-12-10	4	Somaiya Mayur Ian	TCRR	Stock Option (Right to Buy)	A - Award	D	31.83		92,000		92,000
2020-12-11	2020-12-10	4	Hoos Axel	TCRR	Stock Option (Right to Buy)	A - Award	D	31.83		12,100		12,100
2020-11-19	2020-11-17	4	Somaiya Mayur Ian	TCRR	Stock Option (Right to Buy)	M - Exercise	D	5.88		-2,000		104,558
2020-11-19	2020-11-17	4	Somaiya Mayur Ian	TCRR	Common Stock	S - Sale	D		30.0000	-1,666	-50		1,473
2020-11-19	2020-11-17	4	Somaiya Mayur Ian	TCRR	Common Stock	S - Sale	D		30.0000	-2,000	-60		3,139
2020-11-19	2020-11-17	4	Somaiya Mayur Ian	TCRR	Common Stock	M - Exercise	D		5.8800	2,000	12		5,139
2020-11-13	2020-11-12	4	Hofmeister Robert	TCRR	Stock Option (Right to Buy)	M - Exercise	D	0.74		-10,002		25,730
2020-11-13	2020-11-12	4	Hofmeister Robert	TCRR	Stock Option (Right to Buy)	M - Exercise	D	0.74		-9,998		12,348
2020-11-13	2020-11-12	4	Hofmeister Robert	TCRR	Common Stock	S - Sale	D		25.1000	-10,002	-251		38,850
2020-11-13	2020-11-12	4	Hofmeister Robert	TCRR	Common Stock	M - Exercise	D		0.7400	10,002	7		48,852
2020-11-13	2020-11-12	4	Hofmeister Robert	TCRR	Common Stock	S - Sale	D		25.1000	-9,998	-251		38,850
2020-11-13	2020-11-12	4	Hofmeister Robert	TCRR	Common Stock	M - Exercise	D		0.7400	9,998	7		48,848
2020-11-02	2020-10-29	4	Hofmeister Robert	TCRR	Stock Option (Right to Buy)	M - Exercise	D	0.74		-20,000		22,346
2020-11-02	2020-10-29	4	Hofmeister Robert	TCRR	Common Stock	S - Sale	D		19.1000	-20,000	-382		38,850
2020-11-02	2020-10-29	4	Hofmeister Robert	TCRR	Common Stock	M - Exercise	D		0.7400	20,000	15		58,850
2020-05-04	2020-04-30	4	Webster Stephen W	TCRR	Stock Option (Right to Buy)	A - Award	D	9.54		10,482		10,482
2020-04-15	2020-04-13	4	Hoos Axel	TCRR	Stock Option (Right to Buy)	A - Award	D	10.42		9,596		9,596
2020-03-27	2020-02-28	4	Somaiya Mayur Ian	TCRR	Common Stock	A - Award	D		10.1000	1,473	15		3,139
2020-03-27	2019-08-30	4	Somaiya Mayur Ian	TCRR	Common Stock	A - Award	D		12.7500	1,666	21		1,666
2020-03-27	2020-02-28	4	Cardama Alfonso Quintas	TCRR	Common Stock	A - Award	D		10.1000	1,082	11		1,925
2020-03-27	2019-08-30	4	Cardama Alfonso Quintas	TCRR	Common Stock	A - Award	D		12.7500	843	11		843
2020-03-27	2020-02-28	4	Menzel Garry E	TCRR	Common Stock	A - Award	D		10.1000	1,287	13		2,267
2020-03-27	2019-08-30	4	Menzel Garry E	TCRR	Common Stock	A - Award	D		12.7500	980	12		980
2020-03-27	2020-03-20	4	Gibson Neil W see footnote (2)	TCRR	Common Stock	S - Sale	I		7.9400	-648	-5		0
2020-03-27	2020-03-19	4	Gibson Neil W see footnote (2)	TCRR	Common Stock	S - Sale	I		7.4100	-3,140	-23		648
2020-03-27	2020-03-18	4	Gibson Neil W see footnote (2)	TCRR	Common Stock	S - Sale	I		6.8300	-3,120	-21		3,788
2020-03-27	2020-03-17	4	Gibson Neil W see footnote (2)	TCRR	Common Stock	S - Sale	I		6.4900	-3,009	-20		6,908
2020-03-27	2020-03-16	4	Gibson Neil W see footnote (2)	TCRR	Common Stock	S - Sale	I		6.6040	-17,723	-117		9,917
2020-03-27	2020-03-13	4	Gibson Neil W see footnote (2)	TCRR	Common Stock	S - Sale	I		6.5172	-52,000	-339		27,640
2020-03-27	2019-11-15	4	Gibson Neil W see footnote (2)	TCRR	Common Stock	J - Other	I			-217,974			79,640
2020-03-27	2019-11-13	4	Gibson Neil W see footnote (2)	TCRR	Common Stock	J - Other	I			-196,177			297,614
2020-03-27	2019-11-07	4	Gibson Neil W see footnote (2)	TCRR	Common Stock	J - Other	I			-212,560			493,791
2019-12-26	2019-12-23	4	Baeuerle Patrick By APAK Solutions GmbH	TCRR	Common Stock	S - Sale	I		15.4400	-84,907	-1,311		350,786
2019-12-26	2019-12-20	4	Baeuerle Patrick By APAK Solutions GmbH	TCRR	Common Stock	S - Sale	I		15.1600	-32,022	-485		435,693
2019-12-20	2019-12-19	4	Menzel Garry E	TCRR	Stock Option (Right to Buy)	A - Award	D	16.10		168,000		168,000
2019-12-20	2019-12-19	4	Cardama Alfonso Quintas	TCRR	Stock Option (Right to Buy)	A - Award	D	16.10		-72,100		72,100
2019-12-20	2019-12-19	4	Gibson Neil W	TCRR	Stock Option (Right to Buy)	A - Award	D	16.10		5,000		5,000
2019-12-20	2019-12-19	4	Somaiya Mayur Ian	TCRR	Stock Option (Right to Buy)	A - Award	D	16.10		-50,000		50,000
2019-12-20	2019-12-19	4	Allen Andrew R	TCRR	Stock Option (Right to Buy)	A - Award	D	16.10		-5,000		5,000
2019-12-20	2019-12-19	4	Hofmeister Robert	TCRR	Stock Option (Right to Buy)	A - Award	D	16.10		50,000		50,000
2019-12-20	2019-12-20	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	J - Other	I			-13,847			161,024
2019-12-20	2019-12-20	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	J - Other	I			-586,153			713,723
2019-12-20	2019-12-19	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		16.4714	-35,323	-582		155,986
2019-12-20	2019-12-19	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		16.4714	-6,642	-109		82,575
2019-12-20	2019-12-18	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.0060	-2,433	-41		191,309
2019-12-20	2019-12-18	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.0060	-458	-8		89,217
2019-12-11	2019-12-11	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.6525	-4,153	-73		1,299,876
2019-12-11	2019-12-11	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.6525	-1,054	-19		330,238
2019-12-11	2019-12-11	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.6525	-1,381	-24		432,319
2019-12-11	2019-12-11	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.6525	-1,155	-20		361,665
2019-12-11	2019-12-10	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.6232	-30,475	-537		1,304,029
2019-12-11	2019-12-10	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.6232	-7,741	-136		331,292
2019-12-11	2019-12-10	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.6232	-10,135	-179		433,700
2019-12-11	2019-12-10	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.6232	-8,479	-149		362,820
2019-12-11	2019-12-09	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.6511	-75,067	-1,325		1,334,504
2019-12-11	2019-12-09	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.6511	-19,070	-337		339,033
2019-12-11	2019-12-09	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.6511	-24,966	-441		443,835
2019-12-11	2019-12-09	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.6511	-20,886	-369		371,299
2019-10-24	2019-10-22	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		15.1571	-2,085	-32		1,409,571
2019-10-24	2019-10-22	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		15.1571	-530	-8		358,103
2019-10-24	2019-10-22	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		15.1571	-693	-11		392,185
2019-10-24	2019-10-22	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		15.1571	-580	-9		392,185
2019-09-24	2019-09-23	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.3114	-5,516	-95		1,411,656
2019-09-24	2019-09-23	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.3114	-1,401	-24		358,633
2019-09-24	2019-09-23	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.3114	-1,835	-32		469,464
2019-09-24	2019-09-23	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.3114	-351	-6		89,675
2019-09-24	2019-09-23	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.3114	-683	-12		174,871
2019-09-24	2019-09-23	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.3114	-1,535	-27		392,765
2019-09-24	2019-09-20	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.9354	-197,343	-3,539		1,417,172
2019-09-24	2019-09-20	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.9354	-50,134	-899		360,034
2019-09-24	2019-09-20	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.9354	-65,633	-1,177		471,299
2019-09-24	2019-09-20	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.9354	-12,537	-225		90,026
2019-09-24	2019-09-20	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.9354	-24,446	-438		175,554
2019-09-24	2019-09-20	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.9354	-54,907	-985		394,300
2019-09-05	2019-09-04	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.5548	-12,214	-214		102,563
2019-09-05	2019-09-03	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.0142	-10,559	-180		114,777
2019-09-05	2019-08-29	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.0068	-3,700	-63		125,336
2019-09-05	2019-08-28	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.0061	-6,700	-114		129,036
2019-09-05	2019-08-27	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.0113	-1,200	-20		135,736
2019-09-05	2019-08-26	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.0104	-29,128	-495		136,936
2019-09-05	2019-08-23	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.0000	-3	-0		166,064
2019-09-05	2019-08-22	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.0300	-100	-2		166,067
2019-09-05	2019-08-21	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	S - Sale	I		17.0000	-500	-8		166,167
2019-04-12	2019-04-11	4	Hofmeister Robert	TCRR	Stock Option (Right to Buy)	A - Award	D	16.11		127,512		127,512
2019-04-12	2019-04-11	4	Somaiya Mayur Ian	TCRR	Stock Option (Right to Buy)	A - Award	D	16.11		152,307		152,307
2019-04-12	2019-04-11	4	Menzel Garry E	TCRR	Stock Option (Right to Buy)	A - Award	D	16.11		486,106		486,106
2019-04-12	2019-04-11	4	Allen Andrew R	TCRR	Stock Option (Right to Buy)	A - Award	D	16.11		6,270		6,270
2019-04-12	2019-04-11	4	Cardama Alfonso Quintas	TCRR	Stock Option (Right to Buy)	A - Award	D	16.11		211,302		211,302
2019-04-12	2019-04-11	4	Gibson Neil W	TCRR	Stock Option (Right to Buy)	A - Award	D	16.11		6,270		6,270
2019-04-12	2019-04-11	4	Baeuerle Patrick	TCRR	Stock Option (Right to Buy)	A - Award	D	16.11		59,850		59,850
2019-02-21	2019-02-19	4	MPM BioVentures 2014, L.P.	TCRR	Series B Preferred Stock	C - Conversion	I			-2,000,000		0
2019-02-21	2019-02-19	4	MPM BioVentures 2014, L.P.	TCRR	Series A Preferred Stock	C - Conversion	I			-17,500,000		0
2019-02-21	2019-02-19	4	MPM BioVentures 2014, L.P.	TCRR	Common Stock	P - Purchase	I		15.0000	706,666	10,600		4,050,865
2019-02-21	2019-02-19	4	MPM BioVentures 2014, L.P.	TCRR	Common Stock	C - Conversion	I			322,901			3,344,199
2019-02-21	2019-02-19	4	MPM BioVentures 2014, L.P.	TCRR	Common Stock	C - Conversion	I			2,825,396			3,021,298
2019-02-21	2019-02-19	4	MPM SunStates Fund, L.P.	TCRR	Series B Preferred Stock	C - Conversion	I			-2,000,000		0
2019-02-21	2019-02-19	4	MPM SunStates Fund, L.P.	TCRR	Series A Preferred Stock	C - Conversion	I			-17,500,000		0
2019-02-21	2019-02-19	4	MPM SunStates Fund, L.P.	TCRR	Common Stock	P - Purchase	I		15.0000	706,666	10,600		4,050,865
2019-02-21	2019-02-19	4	MPM SunStates Fund, L.P.	TCRR	Common Stock	C - Conversion	I			322,901			3,344,199
2019-02-21	2019-02-19	4	MPM SunStates Fund, L.P.	TCRR	Common Stock	C - Conversion	I			2,825,396			3,021,298
2019-02-21	2019-02-19	4	UBS Oncology Impact Fund L.P.	TCRR	Series B Preferred Stock	C - Conversion	D			-1,750,000		0
2019-02-21	2019-02-19	4	UBS Oncology Impact Fund L.P.	TCRR	Series A Preferred Stock	C - Conversion	D			-15,000,000		0
2019-02-21	2019-02-19	4	UBS Oncology Impact Fund L.P.	TCRR	Common Stock	P - Purchase	D		15.0000	666,667	10,000		3,370,982
2019-02-21	2019-02-19	4	UBS Oncology Impact Fund L.P.	TCRR	Common Stock	C - Conversion	D			282,540			2,704,315
2019-02-21	2019-02-19	4	UBS Oncology Impact Fund L.P.	TCRR	Common Stock	C - Conversion	D			2,421,775			2,421,775
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Series B Preferred Stock	C - Conversion	I			-2,500,000		0
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Series B Preferred Stock	C - Conversion	I			-1,750,000		0
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Series B Preferred Stock	C - Conversion	I			-2,540,500		0
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Series B Preferred Stock	C - Conversion	I			-1,200,000		0
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Series A Preferred Stock	C - Conversion	I			-10,000,001		0
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	P - Purchase	I		15.0000	133,333	2,000		536,962
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	P - Purchase	I		15.0000	166,667	2,500		449,207
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	P - Purchase	I		15.0000	166,667	2,500		449,207
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	P - Purchase	I		15.0000	200,000	3,000		200,000
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	C - Conversion	I			403,629			403,629
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	C - Conversion	I			282,540			282,540
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	C - Conversion	I			410,168			410,168
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	C - Conversion	I			193,742			193,742
2019-02-21	2019-02-19	4	Jovan-Embiricos Morana By Fund	TCRR	Common Stock	C - Conversion	I			1,614,515			1,614,515
2019-02-21	2019-02-19	4	Gibson Neil W	TCRR	Series B Preferred Stock	C - Conversion	I			-4,375,000		0
2019-02-21	2019-02-19	4	Gibson Neil W	TCRR	Common Stock	C - Conversion	I			706,351			706,351
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Series B Preferred Stock	C - Conversion	I			-1,750,000		0
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Series B Preferred Stock	C - Conversion	I			-217,500		0
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Series B Preferred Stock	C - Conversion	I			-1,586,623		0
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Series B Preferred Stock	C - Conversion	I			-105,825		0
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Series B Preferred Stock	C - Conversion	I			-32,500		0
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Series B Preferred Stock	C - Conversion	I			-57,552		0
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Series A Preferred Stock	C - Conversion	I			-15,000,000		0
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Series A Preferred Stock	C - Conversion	I			-2,174,998		0
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Series A Preferred Stock	C - Conversion	I			-13,599,621		0
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Series A Preferred Stock	C - Conversion	I			-907,073		0
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Series A Preferred Stock	C - Conversion	I			-325,002		0
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Series A Preferred Stock	C - Conversion	I			-493,306		0
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	P - Purchase	I		15.0000	1,373,333	20,600		1,569,235
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	C - Conversion	I			282,540			2,704,315
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	C - Conversion	I			35,115			386,270
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	C - Conversion	I			256,163			2,451,844
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	C - Conversion	I			17,085			163,532
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	C - Conversion	I			5,247			57,716
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	C - Conversion	I			9,291			88,935
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	C - Conversion	I			2,421,775			2,421,775
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	C - Conversion	I			351,155			351,155
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	C - Conversion	I			2,195,681			2,195,681
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	C - Conversion	I			146,447			146,447
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	C - Conversion	I			52,469			52,469
2019-02-21	2019-02-19	4	GADICKE ANSBERT	TCRR	Common Stock	C - Conversion	I			79,644			79,644
2019-02-21	2019-02-19	4	Upnorth Investment Ltd By Upnorth Investment Limited	TCRR	Series B Preferred Stock	C - Conversion	I			-10,000,000		0
2019-02-21	2019-02-19	4	Upnorth Investment Ltd By Upnorth Investment Limited	TCRR	Series A Preferred Stock	C - Conversion	I			-2,000,000		0
2019-02-21	2019-02-19	4	Upnorth Investment Ltd By Upnorth Investment Limited	TCRR	Common Stock	P - Purchase	I		15.0000	200,000	3,000		2,137,419
2019-02-21	2019-02-19	4	Upnorth Investment Ltd By Upnorth Investment Limited	TCRR	Common Stock	C - Conversion	I			1,614,517			1,937,419
2019-02-21	2019-02-19	4	Upnorth Investment Ltd By Upnorth Investment Limited	TCRR	Common Stock	C - Conversion	I			322,902			322,902
2019-02-21	2019-02-19	4	Redmile Group, LLC See note	TCRR	Series B Redeemable Convertible Preferred Stock	C - Conversion	I			-5,000,000		0
2019-02-21	2019-02-19	4	Redmile Group, LLC See note	TCRR	Common Stock	C - Conversion	I			807,256			807,256
2019-02-13		3	Finer Mitchell H.	TCRR	Common Stock		D						73,462
2019-02-13		3	Finer Mitchell H.	TCRR	Common Stock		D						73,462
2019-02-13		3	Finer Mitchell H.	TCRR	Common Stock		D						73,462
2019-02-13		3	Baeuerle Patrick By APAK Solutions GmbH	TCRR	Common Stock		I						637,100
2019-02-13		3	Baeuerle Patrick By APAK Solutions GmbH	TCRR	Common Stock		I						637,100
2019-02-13		3	Baeuerle Patrick By APAK Solutions GmbH	TCRR	Common Stock		I						521,167
2019-02-13		3	Baeuerle Patrick By APAK Solutions GmbH	TCRR	Common Stock		I						712,593
2019-02-13		3	Baeuerle Patrick By APAK Solutions GmbH	TCRR	Common Stock		I						637,100
2019-02-13		3	Baeuerle Patrick By APAK Solutions GmbH	TCRR	Common Stock		I						521,167
2019-02-13		3	Baeuerle Patrick By APAK Solutions GmbH	TCRR	Common Stock		I						712,593
2019-02-13		3	Baeuerle Patrick By APAK Solutions GmbH	TCRR	Common Stock		I						521,167
2019-02-13		3	Baeuerle Patrick By APAK Solutions GmbH	TCRR	Common Stock		I						712,593
2019-02-13		3	Menzel Garry E	TCRR	Common Stock		I						169,054
2019-02-13		3	Menzel Garry E	TCRR	Common Stock		I						169,054
2019-02-13		3	Menzel Garry E	TCRR	Common Stock		I						169,054
2019-02-13		3	GADICKE ANSBERT	TCRR	Common Stock		I						391,804
2019-02-13		3	GADICKE ANSBERT	TCRR	Common Stock		I						391,804
2019-02-13		3	GADICKE ANSBERT	TCRR	Common Stock		I						391,804
2019-02-13		3	Hofmeister Robert	TCRR	Common Stock		D						53,563
2019-02-13		3	Hofmeister Robert	TCRR	Common Stock		D						62,987
2019-02-13		3	Hofmeister Robert	TCRR	Common Stock		D						53,563
2019-02-13		3	Hofmeister Robert	TCRR	Common Stock		D						62,987
2019-02-13		3	Hofmeister Robert	TCRR	Common Stock		D						53,563
2019-02-13		3	Hofmeister Robert	TCRR	Common Stock		D						62,987
2019-02-13		3	MPM ASSET MANAGEMENT LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM ASSET MANAGEMENT LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM ASSET MANAGEMENT LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM ASSET MANAGEMENT LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM ASSET MANAGEMENT LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM ASSET MANAGEMENT LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM ASSET MANAGEMENT LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM ASSET MANAGEMENT LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM ASSET MANAGEMENT LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM ASSET MANAGEMENT LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM SunStates GP Managing Member LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM SunStates GP Managing Member LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM SunStates GP Managing Member LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM SunStates GP Managing Member LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM SunStates GP Managing Member LLC	TCRR	Common Stock		I						391,804
2019-02-13		3	MPM SunStates GP Managing Member LLC	TCRR	Common Stock		I						391,804

Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.

Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.

Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)

Konversi turunan

Penjualan atau pengalihan sekuritas kembali ke perusahaan.

Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.

Pemberian sekuritas oleh atau kepada orang dalam.

Swap ekuitas dan transaksi lindung nilai serupa

Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)

Transaksi yang dilaporkan secara sukarela pada Formulir 4.

Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)

TCRR / Tcr2 Therapeutics Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5